TENET HEALTHCARE CORP Equity Method Investment, Summarized Financial Information, Revenue (Deprecated 2020-01-31)
TENET HEALTHCARE CORP (THC) reported Equity Method Investment, Summarized Financial Information, Revenue (Deprecated 2020-01-31) of $566.00 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-04.
Discontinued › Income Statement › Other Income
us-gaap:EquityMethodInvestmentSummarizedFinancialInformationRevenue · last filed 2020-05-04
- TENET HEALTHCARE CORP equity method investment, summarized financial information, revenue (deprecated 2020-01-31) for the quarter ending 2020-03-31 was $566.00M, a 0.35% decline year-over-year.
- TENET HEALTHCARE CORP equity method investment, summarized financial information, revenue (deprecated 2020-01-31) for the quarter ending 2019-12-31 was $871.00M, a 8.60% increase year-over-year.
- TENET HEALTHCARE CORP equity method investment, summarized financial information, revenue (deprecated 2020-01-31) for the quarter ending 2019-09-30 was $622.00M, a 13.92% increase year-over-year.
- TENET HEALTHCARE CORP equity method investment, summarized financial information, revenue (deprecated 2020-01-31) for the quarter ending 2019-06-30 was $619.00M, a 13.16% increase year-over-year.
- TENET HEALTHCARE CORP equity method investment, summarized financial information, revenue (deprecated 2020-01-31) for fiscal 2019 was $2.68B, a 8.55% increase from fiscal 2018.
- TENET HEALTHCARE CORP equity method investment, summarized financial information, revenue (deprecated 2020-01-31) for fiscal 2018 was $2.47B, a 15.07% decline from fiscal 2017.
- TENET HEALTHCARE CORP equity method investment, summarized financial information, revenue (deprecated 2020-01-31) for fiscal 2017 was $2.91B, a 2.98% increase from fiscal 2016.
- TENET HEALTHCARE CORP equity method investment, summarized financial information, revenue (deprecated 2020-01-31) for fiscal 2016 was $2.82B, a 111.46% increase from fiscal 2015.
| Period end | Equity Method Investment, Summarized Financial Information, Revenue (Deprecated 2020-01-31) 3 month | Equity Method Investment, Summarized Financial Information, Revenue (Deprecated 2020-01-31) 6 month | Equity Method Investment, Summarized Financial Information, Revenue (Deprecated 2020-01-31) 9 month | Equity Method Investment, Summarized Financial Information, Revenue (Deprecated 2020-01-31) 12 month |
|---|---|---|---|---|
| 2020-03-31 | $566.00M 10-Q · filed 2020-05-04 | $1.44B derived: sum of 2 quarters · filed 2020-05-04 | $2.06B derived: sum of 3 quarters · filed 2020-05-04 | $2.68B derived: sum of 4 quarters · filed 2020-05-04 |
| 2019-12-31 | $871.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $1.49B derived: sum of 2 quarters · filed 2020-02-24 | $2.11B derived: sum of 3 quarters · filed 2020-02-24 | $2.68B 10-K · filed 2020-02-24 |
| 2019-09-30 | $622.00M 10-Q · filed 2019-11-04 | $1.24B derived: sum of 2 quarters · filed 2019-11-04 | $1.81B 10-Q · filed 2019-11-04 | $2.61B derived: sum of 4 quarters · filed 2020-05-04 |
| 2019-06-30 | $619.00M 10-Q · filed 2019-08-05 | $1.19B 10-Q · filed 2019-08-05 | $1.99B derived: sum of 3 quarters · filed 2020-05-04 | $2.54B derived: sum of 4 quarters · filed 2020-05-04 |
| 2019-03-31 | $568.00M 10-Q · filed 2020-05-04 | $1.37B derived: sum of 2 quarters · filed 2020-05-04 | $1.92B derived: sum of 3 quarters · filed 2020-05-04 | $2.46B derived: sum of 4 quarters · filed 2020-05-04 |
| 2018-12-31 | $802.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $1.35B derived: sum of 2 quarters · filed 2020-02-24 | $1.90B derived: sum of 3 quarters · filed 2020-02-24 | $2.47B 10-K · filed 2020-02-24 |
| 2018-09-30 | $546.00M 10-Q · filed 2019-11-04 | $1.09B derived: sum of 2 quarters · filed 2019-11-04 | $1.67B 10-Q · filed 2019-11-04 | $2.75B derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-06-30 | $547.00M 10-Q · filed 2019-08-05 | $1.12B 10-Q · filed 2019-08-05 | $2.21B derived: sum of 3 quarters · filed 2020-02-24 | $2.84B derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-03-31 | $574.00M 10-Q · filed 2019-04-29 | $1.66B derived: sum of 2 quarters · filed 2020-02-24 | $2.30B derived: sum of 3 quarters · filed 2020-02-24 | $2.90B derived: sum of 4 quarters · filed 2020-02-24 |
| 2017-12-31 | $1.09B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $1.72B derived: sum of 2 quarters · filed 2020-02-24 | $2.32B derived: sum of 3 quarters · filed 2020-02-24 | $2.91B 10-K · filed 2020-02-24 |
| 2017-09-30 | $635.00M 10-Q · filed 2018-11-05 | $1.24B derived: sum of 2 quarters · filed 2018-11-05 | $1.82B 10-Q · filed 2018-11-05 | $2.84B derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-06-30 | $600.00M 10-Q · filed 2018-08-06 | $1.18B 10-Q · filed 2018-08-06 | $2.20B derived: sum of 3 quarters · filed 2019-02-25 | $2.81B derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-03-31 | $584.00M 10-Q · filed 2018-04-30 | $1.60B derived: sum of 2 quarters · filed 2019-02-25 | $2.21B derived: sum of 3 quarters · filed 2019-02-25 | $2.83B derived: sum of 4 quarters · filed 2019-02-25 |
| 2016-12-31 | $1.02B derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $1.63B derived: sum of 2 quarters · filed 2019-02-25 | $2.25B derived: sum of 3 quarters · filed 2019-02-25 | $2.82B 10-K · filed 2019-02-25 |
| 2016-09-30 | $610.00M 10-Q · filed 2017-11-07 | $1.23B derived: sum of 2 quarters · filed 2017-11-07 | $1.80B 10-Q · filed 2017-11-07 | $2.90B derived: sum of 4 quarters · filed 2017-11-07 |
| 2016-06-30 | $615.00M 10-Q · filed 2017-08-07 | $1.19B 10-Q · filed 2017-08-07 | $2.29B derived: sum of 3 quarters · filed 2017-08-07 | $2.49B derived: sum of 4 quarters · filed 2017-08-07 |
| 2016-03-31 | $578.00M 10-Q · filed 2017-05-01 | $1.67B derived: sum of 2 quarters · filed 2017-05-01 | $1.88B derived: sum of 3 quarters · filed 2017-05-01 | |
| 2015-12-31 | $1.09B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $1.30B derived: sum of 2 quarters · filed 2017-02-27 | $1.33B 10-K · filed 2017-02-27 | |
| 2015-09-30 | $206.00M 10-Q · filed 2015-11-02 | $241.00M 10-Q · filed 2015-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Surgery Partners, Inc. (SGRY) | United States | $1.860B | -24.80 |
| Ardent Health, Inc. (ARDT) | United States | $1.478B | 17.91 |
| COMMUNITY HEALTH SYSTEMS INC (CYH) | United States | $0.405B | 1.87 |
| HCA Healthcare, Inc. (HCA) | United States | $93.934B | 15.49 |